Rank | Gene Set | Z-score |
---|---|---|
1 | polyketide metabolic process (GO:0030638) | 5.43359668 |
2 | doxorubicin metabolic process (GO:0044598) | 5.43359668 |
3 | daunorubicin metabolic process (GO:0044597) | 5.43359668 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88035661 |
5 | neutrophil activation involved in immune response (GO:0002283) | 4.76039964 |
6 | establishment of integrated proviral latency (GO:0075713) | 4.48033640 |
7 | ribosome assembly (GO:0042255) | 4.45111112 |
8 | protein localization to kinetochore (GO:0034501) | 4.29692591 |
9 | mitotic metaphase plate congression (GO:0007080) | 4.28945377 |
10 | protein localization to chromosome, centromeric region (GO:0071459) | 4.20586491 |
11 | CENP-A containing nucleosome assembly (GO:0034080) | 4.11390029 |
12 | nuclear pore complex assembly (GO:0051292) | 4.03918368 |
13 | primary alcohol catabolic process (GO:0034310) | 4.03082788 |
14 | chromatin remodeling at centromere (GO:0031055) | 3.94678824 |
15 | establishment of viral latency (GO:0019043) | 3.88286485 |
16 | nuclear pore organization (GO:0006999) | 3.86265956 |
17 | negative regulation of mast cell activation (GO:0033004) | 3.84567090 |
18 | ventricular cardiac muscle cell development (GO:0055015) | 3.84539685 |
19 | mitotic G2/M transition checkpoint (GO:0044818) | 3.83840400 |
20 | metaphase plate congression (GO:0051310) | 3.79427796 |
21 | endosome to pigment granule transport (GO:0043485) | 3.79334237 |
22 | endosome to melanosome transport (GO:0035646) | 3.79334237 |
23 | mitotic chromosome condensation (GO:0007076) | 3.78993737 |
24 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.78660362 |
25 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.75012556 |
26 | reactive oxygen species biosynthetic process (GO:1903409) | 3.74999985 |
27 | establishment of chromosome localization (GO:0051303) | 3.74658916 |
28 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.71622481 |
29 | proteasome assembly (GO:0043248) | 3.69752931 |
30 | superoxide anion generation (GO:0042554) | 3.69746236 |
31 | mitochondrial calcium ion transport (GO:0006851) | 3.69235937 |
32 | DNA strand elongation (GO:0022616) | 3.65278587 |
33 | signal peptide processing (GO:0006465) | 3.63352654 |
34 | COPI coating of Golgi vesicle (GO:0048205) | 3.60825977 |
35 | Golgi transport vesicle coating (GO:0048200) | 3.60825977 |
36 | mitotic sister chromatid segregation (GO:0000070) | 3.59761685 |
37 | DNA unwinding involved in DNA replication (GO:0006268) | 3.55225749 |
38 | respiratory burst (GO:0045730) | 3.55193442 |
39 | sister chromatid segregation (GO:0000819) | 3.54883920 |
40 | positive regulation of B cell differentiation (GO:0045579) | 3.53865593 |
41 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.53368353 |
42 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.52442019 |
43 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.45681498 |
44 | DNA replication checkpoint (GO:0000076) | 3.45114315 |
45 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.43944610 |
46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41040161 |
47 | response to peptidoglycan (GO:0032494) | 3.40563497 |
48 | mitotic sister chromatid cohesion (GO:0007064) | 3.39918187 |
49 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.38247092 |
50 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.32447213 |
51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.31674713 |
52 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.27301104 |
53 | non-recombinational repair (GO:0000726) | 3.27301104 |
54 | spindle checkpoint (GO:0031577) | 3.25636565 |
55 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.25514173 |
56 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.25514173 |
57 | definitive hemopoiesis (GO:0060216) | 3.24485338 |
58 | pore complex assembly (GO:0046931) | 3.21716798 |
59 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.21050047 |
60 | mitotic nuclear envelope disassembly (GO:0007077) | 3.20839218 |
61 | histone exchange (GO:0043486) | 3.19693694 |
62 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.19073504 |
63 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.19073504 |
64 | positive regulation by symbiont of host defense response (GO:0052509) | 3.17147828 |
65 | modulation by symbiont of host defense response (GO:0052031) | 3.17147828 |
66 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.17147828 |
67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.17147828 |
68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.17147828 |
69 | modulation by symbiont of host immune response (GO:0052553) | 3.17147828 |
70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16766293 |
71 | telomere maintenance via recombination (GO:0000722) | 3.16386870 |
72 | ribonucleoprotein complex disassembly (GO:0032988) | 3.15130408 |
73 | positive regulation of interferon-alpha production (GO:0032727) | 3.15099260 |
74 | mitotic spindle checkpoint (GO:0071174) | 3.14177638 |
75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13875770 |
76 | positive regulation of protein sumoylation (GO:0033235) | 3.13504118 |
77 | mitotic recombination (GO:0006312) | 3.12987229 |
78 | neutrophil activation (GO:0042119) | 3.12346965 |
79 | organelle disassembly (GO:1903008) | 3.12119999 |
80 | cellular protein complex localization (GO:0034629) | 3.11726247 |
81 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.09727066 |
82 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.09727066 |
83 | isotype switching (GO:0045190) | 3.09727066 |
84 | regulation of RIG-I signaling pathway (GO:0039535) | 3.05865542 |
85 | positive regulation of interferon-beta production (GO:0032728) | 3.05232135 |
86 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.05170772 |
87 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.05170772 |
88 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.05170772 |
89 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.05170772 |
90 | negative regulation of sister chromatid segregation (GO:0033046) | 3.05170772 |
91 | negative regulation of ligase activity (GO:0051352) | 3.04409393 |
92 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.04409393 |
93 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.04287378 |
94 | immunoglobulin mediated immune response (GO:0016064) | 3.01569941 |
95 | nuclear envelope disassembly (GO:0051081) | 3.01167105 |
96 | membrane disassembly (GO:0030397) | 3.01167105 |
97 | cullin deneddylation (GO:0010388) | 2.98012574 |
98 | negative regulation of chromosome segregation (GO:0051985) | 2.97924629 |
99 | ribosome biogenesis (GO:0042254) | 2.97351210 |
100 | protein deneddylation (GO:0000338) | 2.95309750 |
101 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.95202264 |
102 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.95202264 |
103 | regulation of sister chromatid segregation (GO:0033045) | 2.95202264 |
104 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.95105073 |
105 | granulocyte activation (GO:0036230) | 2.95024073 |
106 | formation of translation preinitiation complex (GO:0001731) | 2.94965848 |
107 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.94837187 |
108 | DNA replication-independent nucleosome organization (GO:0034724) | 2.94837187 |
109 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.94807154 |
110 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.94807154 |
111 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.94807154 |
112 | mitotic spindle assembly checkpoint (GO:0007094) | 2.94657532 |
113 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.92353839 |
114 | cell cycle G1/S phase transition (GO:0044843) | 2.92353839 |
115 | regulation of B cell differentiation (GO:0045577) | 2.91290136 |
116 | centriole replication (GO:0007099) | 2.90769901 |
117 | DNA double-strand break processing (GO:0000729) | 2.90682953 |
118 | spindle assembly checkpoint (GO:0071173) | 2.90131124 |
119 | negative regulation of phagocytosis (GO:0050765) | 2.88764793 |
120 | regulation of interferon-alpha production (GO:0032647) | 2.88171365 |
121 | positive regulation of ligase activity (GO:0051351) | 2.87334090 |
122 | regulation of mast cell activation (GO:0033003) | 2.87265461 |
123 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.86977759 |
124 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.86900922 |
125 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.86900922 |
126 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.86900922 |
127 | response to X-ray (GO:0010165) | 2.86862302 |
128 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.86464754 |
129 | detection of other organism (GO:0098543) | 2.85741764 |
130 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.85023732 |
131 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.85023732 |
132 | protein localization to chromosome (GO:0034502) | 2.84054037 |
133 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.83936141 |
134 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.82500406 |
135 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.82016883 |
136 | positive regulation of chromosome segregation (GO:0051984) | 2.81576457 |
137 | regulation of chromosome segregation (GO:0051983) | 2.80976431 |
138 | response to UV-C (GO:0010225) | 2.80524314 |
139 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.80298762 |
140 | positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) | 2.78767076 |
141 | neural tube formation (GO:0001841) | 2.78083205 |
142 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.77654746 |
143 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.77628377 |
144 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.77628377 |
145 | regulation of mast cell degranulation (GO:0043304) | 2.74230698 |
146 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71484628 |
147 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.71125529 |
148 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70965718 |
149 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.67212390 |
150 | ethanol oxidation (GO:0006069) | 2.66626373 |
151 | detection of molecule of bacterial origin (GO:0032490) | 2.63270541 |
152 | necroptotic process (GO:0070266) | 2.60192922 |
153 | response to host immune response (GO:0052572) | 2.60047536 |
154 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60047536 |
155 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.59328043 |
156 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.58269925 |
157 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.57156913 |
158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57153149 |
159 | tryptophan metabolic process (GO:0006568) | 2.54827319 |
160 | programmed necrotic cell death (GO:0097300) | 2.54019455 |
161 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53324238 |
162 | protein carboxylation (GO:0018214) | 2.51651512 |
163 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.51651512 |
164 | indole-containing compound catabolic process (GO:0042436) | 2.51450144 |
165 | indolalkylamine catabolic process (GO:0046218) | 2.51450144 |
166 | tryptophan catabolic process (GO:0006569) | 2.51450144 |
167 | toxin transport (GO:1901998) | 2.49792339 |
168 | regulation of lipoprotein particle clearance (GO:0010984) | 2.44238940 |
169 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.43937559 |
170 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.43930862 |
171 | hepatocyte apoptotic process (GO:0097284) | 2.43553043 |
172 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.43474110 |
173 | glucosamine-containing compound catabolic process (GO:1901072) | 2.43081426 |
174 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.42433857 |
175 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.42408035 |
176 | ER overload response (GO:0006983) | 2.42358299 |
177 | glycoside metabolic process (GO:0016137) | 2.42074767 |
178 | organelle membrane fusion (GO:0090174) | 2.41764309 |
179 | intra-S DNA damage checkpoint (GO:0031573) | 2.38780103 |
180 | necrotic cell death (GO:0070265) | 2.37851810 |
181 | detection of external biotic stimulus (GO:0098581) | 2.35844634 |
182 | aldehyde catabolic process (GO:0046185) | 2.35721861 |
183 | positive regulation of respiratory burst (GO:0060267) | 2.35562254 |
184 | response to type I interferon (GO:0034340) | 2.32742098 |
185 | type I interferon signaling pathway (GO:0060337) | 2.31212166 |
186 | cellular response to type I interferon (GO:0071357) | 2.31212166 |
187 | regulation of hexokinase activity (GO:1903299) | 2.31181560 |
188 | regulation of glucokinase activity (GO:0033131) | 2.31181560 |
189 | autophagic vacuole fusion (GO:0000046) | 2.30905374 |
190 | myeloid cell activation involved in immune response (GO:0002275) | 2.30464906 |
191 | detection of bacterium (GO:0016045) | 2.30453210 |
192 | microglial cell activation (GO:0001774) | 2.29277123 |
193 | negative regulation of viral genome replication (GO:0045071) | 2.26639991 |
194 | DNA ligation (GO:0006266) | 2.26006431 |
195 | L-fucose catabolic process (GO:0042355) | 2.22768061 |
196 | fucose catabolic process (GO:0019317) | 2.22768061 |
197 | L-fucose metabolic process (GO:0042354) | 2.22768061 |
198 | ribosomal small subunit assembly (GO:0000028) | 2.21677077 |
199 | positive regulation of macrophage differentiation (GO:0045651) | 2.21486843 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.44194444 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.45264519 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.42249412 |
4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.10149446 |
5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82028239 |
6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.77326641 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.67381733 |
8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.61491423 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.53013146 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43825883 |
11 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.41612134 |
12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.35670637 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33384261 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.32044409 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29896354 |
16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29576240 |
17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.26703896 |
18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.23703524 |
19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22421575 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.16785575 |
21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15900347 |
22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.15013327 |
23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12127336 |
24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.11466541 |
25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.08993465 |
26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.08352799 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.07234629 |
28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06591303 |
29 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.05086931 |
30 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.01233623 |
31 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98931464 |
32 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.98540270 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97635558 |
34 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.97540461 |
35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97002246 |
36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.95973921 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93643532 |
38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93204314 |
39 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.91962396 |
40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84634856 |
41 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82297392 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79981591 |
43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79430442 |
44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77670581 |
45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.76650606 |
46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76245182 |
47 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.73804942 |
48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.71709329 |
49 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.66109842 |
50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.64450599 |
51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64442742 |
52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63296211 |
53 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.61458415 |
54 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.60006052 |
55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.58622638 |
56 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.54028288 |
57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.53105864 |
58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52341798 |
59 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51419702 |
60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51245121 |
61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50564684 |
62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.50084190 |
63 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.48579809 |
64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45793692 |
65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.45115234 |
66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.44605903 |
67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44361169 |
68 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.43854906 |
69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43543421 |
70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43416574 |
71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42400307 |
72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.41527765 |
73 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.41462469 |
74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41308727 |
75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39045755 |
76 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38809414 |
77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36159592 |
78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35982283 |
79 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35359205 |
80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34838229 |
81 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.34537236 |
82 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.31295447 |
83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31135401 |
84 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.30186282 |
85 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27324241 |
86 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26825957 |
87 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26112983 |
88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22786767 |
89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21147869 |
90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18715960 |
91 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.16379997 |
92 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14832573 |
93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14658480 |
94 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14243873 |
95 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13948926 |
96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13732457 |
97 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12583687 |
98 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12532646 |
99 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11708007 |
100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.11590455 |
101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09768720 |
102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07746213 |
103 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07436981 |
104 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07121330 |
105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05839329 |
106 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.04769845 |
107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04678684 |
108 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.04445049 |
109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04219849 |
110 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03909900 |
111 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02891877 |
112 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.02676225 |
113 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02027926 |
114 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01985947 |
115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00653606 |
116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00503086 |
117 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00402119 |
118 | MYB_26560356_Chip-Seq_TH2_Human | 1.00030088 |
119 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99794968 |
120 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99755140 |
121 | MYB_26560356_Chip-Seq_TH1_Human | 0.97701644 |
122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97462402 |
123 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97202275 |
124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97168837 |
125 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95969028 |
126 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.95284304 |
127 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94571613 |
128 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94395472 |
129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94349985 |
130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93136474 |
131 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92618545 |
132 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92075221 |
133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91713690 |
134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91180879 |
135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90992582 |
136 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90772162 |
137 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89288624 |
138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89029668 |
139 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88512743 |
140 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.88423105 |
141 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88420546 |
142 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85409646 |
143 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.82472410 |
144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81930160 |
145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78442272 |
146 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.77692848 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003183_abnormal_peptide_metabolism | 4.80335233 |
2 | MP0003111_abnormal_nucleus_morphology | 3.52072341 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.28197992 |
4 | MP0001835_abnormal_antigen_presentation | 3.23102060 |
5 | MP0000569_abnormal_digit_pigmentation | 3.19975480 |
6 | MP0003195_calcinosis | 3.18359372 |
7 | MP0003077_abnormal_cell_cycle | 3.04618069 |
8 | MP0010352_gastrointestinal_tract_polyps | 3.02307374 |
9 | MP0005058_abnormal_lysosome_morphology | 2.64677068 |
10 | MP0002139_abnormal_hepatobiliary_system | 2.61485879 |
11 | MP0010386_abnormal_urinary_bladder | 2.60144407 |
12 | MP0003221_abnormal_cardiomyocyte_apopto | 2.47977339 |
13 | MP0008932_abnormal_embryonic_tissue | 2.39952457 |
14 | MP0005360_urolithiasis | 2.39888205 |
15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36779583 |
16 | MP0009697_abnormal_copulation | 2.27834234 |
17 | MP0002419_abnormal_innate_immunity | 2.21480506 |
18 | MP0003718_maternal_effect | 2.20904227 |
19 | MP0001853_heart_inflammation | 2.20870231 |
20 | MP0003172_abnormal_lysosome_physiology | 2.16511302 |
21 | MP0005365_abnormal_bile_salt | 1.97712507 |
22 | MP0005670_abnormal_white_adipose | 1.93905038 |
23 | MP0003436_decreased_susceptibility_to | 1.92971881 |
24 | MP0005464_abnormal_platelet_physiology | 1.92573457 |
25 | MP0003890_abnormal_embryonic-extraembry | 1.90891148 |
26 | MP0002148_abnormal_hypersensitivity_rea | 1.89833958 |
27 | MP0005085_abnormal_gallbladder_physiolo | 1.89726338 |
28 | MP0000350_abnormal_cell_proliferation | 1.89435039 |
29 | MP0003724_increased_susceptibility_to | 1.85922615 |
30 | MP0009785_altered_susceptibility_to | 1.85604017 |
31 | MP0000015_abnormal_ear_pigmentation | 1.84664432 |
32 | MP0003806_abnormal_nucleotide_metabolis | 1.80060612 |
33 | MP0003656_abnormal_erythrocyte_physiolo | 1.76078443 |
34 | MP0009764_decreased_sensitivity_to | 1.74641289 |
35 | MP0001730_embryonic_growth_arrest | 1.72877406 |
36 | MP0001764_abnormal_homeostasis | 1.72078577 |
37 | MP0005025_abnormal_response_to | 1.70940721 |
38 | MP0010234_abnormal_vibrissa_follicle | 1.66543778 |
39 | MP0002452_abnormal_antigen_presenting | 1.64552035 |
40 | MP0002396_abnormal_hematopoietic_system | 1.61437128 |
41 | MP0003252_abnormal_bile_duct | 1.60894168 |
42 | MP0001800_abnormal_humoral_immune | 1.60713117 |
43 | MP0001790_abnormal_immune_system | 1.59634999 |
44 | MP0005387_immune_system_phenotype | 1.59634999 |
45 | MP0000013_abnormal_adipose_tissue | 1.59135122 |
46 | MP0003303_peritoneal_inflammation | 1.57736365 |
47 | MP0004019_abnormal_vitamin_homeostasis | 1.56223146 |
48 | MP0005000_abnormal_immune_tolerance | 1.54995114 |
49 | MP0005174_abnormal_tail_pigmentation | 1.54918280 |
50 | MP0005671_abnormal_response_to | 1.54649839 |
51 | MP0004233_abnormal_muscle_weight | 1.53086478 |
52 | MP0002132_abnormal_respiratory_system | 1.52607451 |
53 | MP0001529_abnormal_vocalization | 1.51393356 |
54 | MP0002723_abnormal_immune_serum | 1.51376069 |
55 | MP0004510_myositis | 1.48515030 |
56 | MP0000313_abnormal_cell_death | 1.46417778 |
57 | MP0010307_abnormal_tumor_latency | 1.45259409 |
58 | MP0002420_abnormal_adaptive_immunity | 1.44168886 |
59 | MP0005647_abnormal_sex_gland | 1.43796077 |
60 | MP0001819_abnormal_immune_cell | 1.43765421 |
61 | MP0004808_abnormal_hematopoietic_stem | 1.41214852 |
62 | MP0006292_abnormal_olfactory_placode | 1.40047708 |
63 | MP0001986_abnormal_taste_sensitivity | 1.38646725 |
64 | MP0003950_abnormal_plasma_membrane | 1.38633437 |
65 | MP0008469_abnormal_protein_level | 1.37940319 |
66 | MP0005451_abnormal_body_composition | 1.34495380 |
67 | MP0004264_abnormal_extraembryonic_tissu | 1.33586828 |
68 | MP0008057_abnormal_DNA_replication | 1.32917021 |
69 | MP0002138_abnormal_hepatobiliary_system | 1.28852580 |
70 | MP0003186_abnormal_redox_activity | 1.28637065 |
71 | MP0000465_gastrointestinal_hemorrhage | 1.27140202 |
72 | MP0004782_abnormal_surfactant_physiolog | 1.26945133 |
73 | MP0002693_abnormal_pancreas_physiology | 1.26666817 |
74 | MP0002876_abnormal_thyroid_physiology | 1.24961021 |
75 | MP0001293_anophthalmia | 1.24513279 |
76 | MP0005646_abnormal_pituitary_gland | 1.24024345 |
77 | MP0001672_abnormal_embryogenesis/_devel | 1.23735463 |
78 | MP0005380_embryogenesis_phenotype | 1.23735463 |
79 | MP0001697_abnormal_embryo_size | 1.22054307 |
80 | MP0001845_abnormal_inflammatory_respons | 1.22024872 |
81 | MP0008058_abnormal_DNA_repair | 1.21188406 |
82 | MP0002877_abnormal_melanocyte_morpholog | 1.20492411 |
83 | MP0002398_abnormal_bone_marrow | 1.17153296 |
84 | MP0001186_pigmentation_phenotype | 1.16195051 |
85 | MP0004185_abnormal_adipocyte_glucose | 1.15700358 |
86 | MP0000371_diluted_coat_color | 1.15544114 |
87 | MP0001188_hyperpigmentation | 1.15538501 |
88 | MP0000716_abnormal_immune_system | 1.13931064 |
89 | MP0002928_abnormal_bile_duct | 1.13889222 |
90 | MP0001879_abnormal_lymphatic_vessel | 1.11784908 |
91 | MP0000358_abnormal_cell_content/ | 1.11399762 |
92 | MP0004197_abnormal_fetal_growth/weight/ | 1.11113045 |
93 | MP0006082_CNS_inflammation | 1.10882935 |
94 | MP0002095_abnormal_skin_pigmentation | 1.09215313 |
95 | MP0003943_abnormal_hepatobiliary_system | 1.09013455 |
96 | MP0002080_prenatal_lethality | 1.08602598 |
97 | MP0008260_abnormal_autophagy | 1.08497719 |
98 | MP0000538_abnormal_urinary_bladder | 1.07141796 |
99 | MP0006035_abnormal_mitochondrial_morpho | 1.05925354 |
100 | MP0002277_abnormal_respiratory_mucosa | 1.05640918 |
101 | MP0003646_muscle_fatigue | 1.05420328 |
102 | MP0002332_abnormal_exercise_endurance | 1.04845132 |
103 | MP0005379_endocrine/exocrine_gland_phen | 1.04794755 |
104 | MP0000689_abnormal_spleen_morphology | 1.04723463 |
105 | MP0003191_abnormal_cellular_cholesterol | 1.02968026 |
106 | MP0001533_abnormal_skeleton_physiology | 1.02792287 |
107 | MP0000516_abnormal_urinary_system | 1.00834449 |
108 | MP0005367_renal/urinary_system_phenotyp | 1.00834449 |
109 | MP0003763_abnormal_thymus_physiology | 1.00613559 |
110 | MP0002429_abnormal_blood_cell | 1.00450612 |
111 | MP0003984_embryonic_growth_retardation | 1.00113653 |
112 | MP0005266_abnormal_metabolism | 0.99808291 |
113 | MP0004215_abnormal_myocardial_fiber | 0.98983111 |
114 | MP0003448_altered_tumor_morphology | 0.98547550 |
115 | MP0002088_abnormal_embryonic_growth/wei | 0.96420065 |
116 | MP0004147_increased_porphyrin_level | 0.95558370 |
117 | MP0001666_abnormal_nutrient_absorption | 0.95557928 |
118 | MP0008007_abnormal_cellular_replicative | 0.94668284 |
119 | MP0006054_spinal_hemorrhage | 0.94411578 |
120 | MP0002084_abnormal_developmental_patter | 0.93955612 |
121 | MP0010329_abnormal_lipoprotein_level | 0.93283919 |
122 | MP0010094_abnormal_chromosome_stability | 0.93263018 |
123 | MP0000609_abnormal_liver_physiology | 0.93113655 |
124 | MP0002009_preneoplasia | 0.92495364 |
125 | MP0003693_abnormal_embryo_hatching | 0.92124646 |
126 | MP0002796_impaired_skin_barrier | 0.91563910 |
127 | MP0002405_respiratory_system_inflammati | 0.90633415 |
128 | MP0008789_abnormal_olfactory_epithelium | 0.90020227 |
129 | MP0003787_abnormal_imprinting | 0.89691998 |
130 | MP0002019_abnormal_tumor_incidence | 0.89250486 |
131 | MP0001545_abnormal_hematopoietic_system | 0.89173259 |
132 | MP0005397_hematopoietic_system_phenotyp | 0.89173259 |
133 | MP0003786_premature_aging | 0.87626830 |
134 | MP0005319_abnormal_enzyme/_coenzyme | 0.87457657 |
135 | MP0003828_pulmonary_edema | 0.87447433 |
136 | MP0000490_abnormal_crypts_of | 0.87414722 |
137 | MP0002638_abnormal_pupillary_reflex | 0.86600129 |
138 | MP0005084_abnormal_gallbladder_morpholo | 0.86347696 |
139 | MP0002075_abnormal_coat/hair_pigmentati | 0.86187252 |
140 | MP0003453_abnormal_keratinocyte_physiol | 0.85320972 |
141 | MP0005623_abnormal_meninges_morphology | 0.84415524 |
142 | MP0006036_abnormal_mitochondrial_physio | 0.83627356 |
143 | MP0000598_abnormal_liver_morphology | 0.83174667 |
144 | MP0005645_abnormal_hypothalamus_physiol | 0.83111060 |
145 | MP0005220_abnormal_exocrine_pancreas | 0.82495589 |
146 | MP0002722_abnormal_immune_system | 0.82082741 |
147 | MP0004043_abnormal_pH_regulation | 0.81524448 |
148 | MP0003941_abnormal_skin_development | 0.81282896 |
149 | MP0000685_abnormal_immune_system | 0.80616328 |
150 | MP0002085_abnormal_embryonic_tissue | 0.80414190 |
151 | MP0005384_cellular_phenotype | 0.79854507 |
152 | MP0002006_tumorigenesis | 0.79482520 |
153 | MP0001243_abnormal_dermal_layer | 0.78420537 |
154 | MP0005621_abnormal_cell_physiology | 0.77605882 |
155 | MP0000749_muscle_degeneration | 0.77284383 |
156 | MP0001915_intracranial_hemorrhage | 0.76310733 |
157 | MP0001727_abnormal_embryo_implantation | 0.76086538 |
158 | MP0002269_muscular_atrophy | 0.75751523 |
159 | MP0005395_other_phenotype | 0.75097922 |
160 | MP0001216_abnormal_epidermal_layer | 0.74301262 |
161 | MP0010368_abnormal_lymphatic_system | 0.70190303 |
162 | MP0002102_abnormal_ear_morphology | 0.69730777 |
163 | MP0002086_abnormal_extraembryonic_tissu | 0.69066191 |
164 | MP0002092_abnormal_eye_morphology | 0.68152859 |
165 | MP0005501_abnormal_skin_physiology | 0.66267520 |
166 | MP0002233_abnormal_nose_morphology | 0.65998356 |
167 | MP0000703_abnormal_thymus_morphology | 0.65548996 |
168 | MP0005376_homeostasis/metabolism_phenot | 0.64949537 |
169 | MP0009765_abnormal_xenobiotic_induced | 0.62780358 |
170 | MP0009115_abnormal_fat_cell | 0.60804417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged partial thromboplastin time (HP:0003645) | 4.01434581 |
2 | Joint hemorrhage (HP:0005261) | 3.85728904 |
3 | Papillary thyroid carcinoma (HP:0002895) | 3.77175813 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66221979 |
5 | Reduced antithrombin III activity (HP:0001976) | 3.64875741 |
6 | Chromsome breakage (HP:0040012) | 3.59048192 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.58476429 |
8 | Recurrent abscess formation (HP:0002722) | 3.54587697 |
9 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.52832836 |
10 | Renal cortical cysts (HP:0000803) | 3.37263143 |
11 | Mutism (HP:0002300) | 3.36585089 |
12 | Medulloblastoma (HP:0002885) | 3.30358407 |
13 | Abnormality of chromosome stability (HP:0003220) | 3.24730780 |
14 | Disinhibition (HP:0000734) | 3.18066717 |
15 | Eczematoid dermatitis (HP:0000976) | 3.15756762 |
16 | Gonadotropin excess (HP:0000837) | 3.11685548 |
17 | Cortical dysplasia (HP:0002539) | 3.09086470 |
18 | Neoplasm of the adrenal gland (HP:0100631) | 3.02750101 |
19 | Neoplasm of the adrenal cortex (HP:0100641) | 3.01574250 |
20 | Hypoglycemic coma (HP:0001325) | 2.98723153 |
21 | Thyroid carcinoma (HP:0002890) | 2.96490601 |
22 | Abnormality of the intrinsic pathway (HP:0010989) | 2.93263480 |
23 | Rhabdomyosarcoma (HP:0002859) | 2.91800146 |
24 | Hypothermia (HP:0002045) | 2.79550543 |
25 | Nemaline bodies (HP:0003798) | 2.78923823 |
26 | Abnormality of the preputium (HP:0100587) | 2.75809782 |
27 | Limb hypertonia (HP:0002509) | 2.73421056 |
28 | Generalized aminoaciduria (HP:0002909) | 2.70300494 |
29 | Vacuolated lymphocytes (HP:0001922) | 2.68323099 |
30 | Meckel diverticulum (HP:0002245) | 2.67118200 |
31 | Exercise-induced muscle cramps (HP:0003710) | 2.66413058 |
32 | Hypoglycemic seizures (HP:0002173) | 2.66054016 |
33 | Type I transferrin isoform profile (HP:0003642) | 2.64356752 |
34 | Abnormal lung lobation (HP:0002101) | 2.61568790 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.58989613 |
36 | Agnosia (HP:0010524) | 2.58573422 |
37 | Increased serum pyruvate (HP:0003542) | 2.56476838 |
38 | Multiple enchondromatosis (HP:0005701) | 2.56038332 |
39 | Abnormality of DNA repair (HP:0003254) | 2.51140877 |
40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50043752 |
41 | Embryonal renal neoplasm (HP:0011794) | 2.49051285 |
42 | Dyschromatopsia (HP:0007641) | 2.48878957 |
43 | Abnormality of the common coagulation pathway (HP:0010990) | 2.45456262 |
44 | Curly hair (HP:0002212) | 2.44994575 |
45 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.44420146 |
46 | Abnormality of the ileum (HP:0001549) | 2.43527000 |
47 | Retrobulbar optic neuritis (HP:0100654) | 2.43132152 |
48 | Optic neuritis (HP:0100653) | 2.43132152 |
49 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.41090185 |
50 | Colon cancer (HP:0003003) | 2.40643421 |
51 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.40214891 |
52 | Thrombocytosis (HP:0001894) | 2.39235321 |
53 | Abnormality of macrophages (HP:0004311) | 2.39031755 |
54 | Muscle fiber inclusion bodies (HP:0100299) | 2.36578836 |
55 | Prostate neoplasm (HP:0100787) | 2.34267850 |
56 | Periodontitis (HP:0000704) | 2.34132487 |
57 | Orchitis (HP:0100796) | 2.31651733 |
58 | Abnormality of the anterior horn cell (HP:0006802) | 2.30503800 |
59 | Degeneration of anterior horn cells (HP:0002398) | 2.30503800 |
60 | Myositis (HP:0100614) | 2.29824919 |
61 | Abnormality of lateral ventricle (HP:0030047) | 2.27867147 |
62 | Neoplasm of the colon (HP:0100273) | 2.27686648 |
63 | Aplastic anemia (HP:0001915) | 2.25101754 |
64 | Capillary hemangiomas (HP:0005306) | 2.25098500 |
65 | Pigmentary retinal degeneration (HP:0001146) | 2.22081706 |
66 | IgM deficiency (HP:0002850) | 2.21167519 |
67 | Increased cerebral lipofuscin (HP:0011813) | 2.20416173 |
68 | Nausea (HP:0002018) | 2.20279832 |
69 | Gingivitis (HP:0000230) | 2.19583171 |
70 | Oral leukoplakia (HP:0002745) | 2.19395419 |
71 | Entropion (HP:0000621) | 2.18173523 |
72 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.17249444 |
73 | Subaortic stenosis (HP:0001682) | 2.17249444 |
74 | Abnormality of glycolysis (HP:0004366) | 2.16895278 |
75 | Loss of speech (HP:0002371) | 2.16442056 |
76 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.16412597 |
77 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.16412597 |
78 | Single umbilical artery (HP:0001195) | 2.16412597 |
79 | Hypoplasia of the thymus (HP:0000778) | 2.16241427 |
80 | Symptomatic seizures (HP:0011145) | 2.15351168 |
81 | Microglossia (HP:0000171) | 2.15066468 |
82 | Cystic hygroma (HP:0000476) | 2.14853028 |
83 | Proximal tubulopathy (HP:0000114) | 2.14349754 |
84 | Small intestinal stenosis (HP:0012848) | 2.13625366 |
85 | Duodenal stenosis (HP:0100867) | 2.13625366 |
86 | Abnormality of the renal cortex (HP:0011035) | 2.12535672 |
87 | Mediastinal lymphadenopathy (HP:0100721) | 2.11856715 |
88 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.11829899 |
89 | Increased hepatocellular lipid droplets (HP:0006565) | 2.11499843 |
90 | Sensorimotor neuropathy (HP:0007141) | 2.09313892 |
91 | Abnormal hair whorl (HP:0010721) | 2.08876305 |
92 | Deep philtrum (HP:0002002) | 2.07716684 |
93 | Basal ganglia calcification (HP:0002135) | 2.07132934 |
94 | Recurrent skin infections (HP:0001581) | 2.03473261 |
95 | Palpitations (HP:0001962) | 2.03191105 |
96 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02952243 |
97 | Acute necrotizing encephalopathy (HP:0006965) | 2.02299305 |
98 | Acute myeloid leukemia (HP:0004808) | 2.01500772 |
99 | Type 2 muscle fiber atrophy (HP:0003554) | 2.01238397 |
100 | Impaired platelet aggregation (HP:0003540) | 2.01182425 |
101 | Abnormal platelet function (HP:0011869) | 2.01182425 |
102 | Syringomyelia (HP:0003396) | 2.00601324 |
103 | Spinal cord lesions (HP:0100561) | 2.00601324 |
104 | Abnormality of methionine metabolism (HP:0010901) | 2.00428985 |
105 | Freckling (HP:0001480) | 2.00264768 |
106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99657521 |
107 | Osteomyelitis (HP:0002754) | 1.99217667 |
108 | Abnormality of the prostate (HP:0008775) | 1.98235997 |
109 | Menorrhagia (HP:0000132) | 1.97889281 |
110 | Gingival bleeding (HP:0000225) | 1.97871772 |
111 | Progressive muscle weakness (HP:0003323) | 1.96933597 |
112 | Encephalitis (HP:0002383) | 1.96637667 |
113 | Volvulus (HP:0002580) | 1.96404149 |
114 | Keratoconjunctivitis sicca (HP:0001097) | 1.95504748 |
115 | Facial hemangioma (HP:0000329) | 1.95265220 |
116 | Upper motor neuron abnormality (HP:0002127) | 1.94810114 |
117 | Shoulder girdle muscle weakness (HP:0003547) | 1.94569985 |
118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94155371 |
119 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94155371 |
120 | Abnormal protein glycosylation (HP:0012346) | 1.94155371 |
121 | Abnormal glycosylation (HP:0012345) | 1.94155371 |
122 | Secondary amenorrhea (HP:0000869) | 1.93347111 |
123 | Hypobetalipoproteinemia (HP:0003563) | 1.93199911 |
124 | Constricted visual fields (HP:0001133) | 1.91789173 |
125 | Recurrent fungal infections (HP:0002841) | 1.91648666 |
126 | Abnormality of alanine metabolism (HP:0010916) | 1.91423586 |
127 | Hyperalaninemia (HP:0003348) | 1.91423586 |
128 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91423586 |
129 | Premature ovarian failure (HP:0008209) | 1.91005371 |
130 | Microvesicular hepatic steatosis (HP:0001414) | 1.90795001 |
131 | Abnormality of urine glucose concentration (HP:0011016) | 1.89983534 |
132 | Glycosuria (HP:0003076) | 1.89983534 |
133 | Melanoma (HP:0002861) | 1.89922531 |
134 | Neoplasm of the small intestine (HP:0100833) | 1.89783985 |
135 | Retinal atrophy (HP:0001105) | 1.88807949 |
136 | Myelodysplasia (HP:0002863) | 1.87856099 |
137 | Neuroblastoma (HP:0003006) | 1.87646514 |
138 | Primitive neuroectodermal tumor (HP:0030065) | 1.87646514 |
139 | Neuroblastic tumors (HP:0004376) | 1.87646514 |
140 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.87646514 |
141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87315655 |
142 | Progressive external ophthalmoplegia (HP:0000590) | 1.87115483 |
143 | Viral hepatitis (HP:0006562) | 1.86884313 |
144 | Short middle phalanx of the 5th finger (HP:0004220) | 1.86526466 |
145 | Posterior subcapsular cataract (HP:0007787) | 1.85585104 |
146 | Cutaneous melanoma (HP:0012056) | 1.85243243 |
147 | Keratitis (HP:0000491) | 1.84338166 |
148 | Epistaxis (HP:0000421) | 1.83635337 |
149 | Subacute progressive viral hepatitis (HP:0006572) | 1.82589004 |
150 | Acute encephalopathy (HP:0006846) | 1.82535326 |
151 | Abnormality of the septum pellucidum (HP:0007375) | 1.82534742 |
152 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82176639 |
153 | Obstructive lung disease (HP:0006536) | 1.82088405 |
154 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82088405 |
155 | Autoamputation (HP:0001218) | 1.81408702 |
156 | Spontaneous hematomas (HP:0007420) | 1.81159813 |
157 | Alveolar cell carcinoma (HP:0006519) | 1.80634200 |
158 | Inappropriate behavior (HP:0000719) | 1.80276417 |
159 | Abnormal foot bone ossification (HP:0010675) | 1.80023894 |
160 | Prolonged bleeding time (HP:0003010) | 1.79605422 |
161 | Biliary tract neoplasm (HP:0100574) | 1.77963562 |
162 | Neuroendocrine neoplasm (HP:0100634) | 1.77963254 |
163 | Fair hair (HP:0002286) | 1.76511061 |
164 | Vasculitis (HP:0002633) | 1.76330865 |
165 | Lipid accumulation in hepatocytes (HP:0006561) | 1.75413048 |
166 | Meningitis (HP:0001287) | 1.74196146 |
167 | Apathy (HP:0000741) | 1.74084342 |
168 | Uterine neoplasm (HP:0010784) | 1.73790824 |
169 | Hepatosplenomegaly (HP:0001433) | 1.72722629 |
170 | Recurrent sinusitis (HP:0011108) | 1.72584175 |
171 | Osteomalacia (HP:0002749) | 1.72111130 |
172 | Abnormality of the basal ganglia (HP:0002134) | 1.71427363 |
173 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.71336422 |
174 | Tetany (HP:0001281) | 1.71129193 |
175 | Dysostosis multiplex (HP:0000943) | 1.71076046 |
176 | B lymphocytopenia (HP:0010976) | 1.69855030 |
177 | Abnormality of B cell number (HP:0010975) | 1.69855030 |
178 | Renal Fanconi syndrome (HP:0001994) | 1.69734199 |
179 | Keratoconjunctivitis (HP:0001096) | 1.69469354 |
180 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.69139754 |
181 | Cerebral palsy (HP:0100021) | 1.67994051 |
182 | Hepatic necrosis (HP:0002605) | 1.67603579 |
183 | Progressive macrocephaly (HP:0004481) | 1.66783824 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SIK3 | 3.60114294 |
2 | TAOK3 | 3.46186724 |
3 | IRAK4 | 3.15450707 |
4 | PBK | 3.08748627 |
5 | TRIM28 | 3.07708213 |
6 | IRAK3 | 2.91490790 |
7 | CDC7 | 2.75988705 |
8 | KIT | 2.72644863 |
9 | TTK | 2.42512353 |
10 | SGK2 | 2.22685004 |
11 | NEK1 | 2.21657286 |
12 | STK16 | 2.17161787 |
13 | PLK4 | 2.13353641 |
14 | RIPK4 | 2.12758293 |
15 | ZAK | 2.12119750 |
16 | WEE1 | 2.05277702 |
17 | TEC | 2.03304544 |
18 | VRK2 | 2.02641114 |
19 | INSRR | 2.00388966 |
20 | MAP2K3 | 1.99706320 |
21 | MAP3K3 | 1.83252954 |
22 | ERBB3 | 1.82342698 |
23 | MAP3K14 | 1.77701518 |
24 | AKT3 | 1.76839446 |
25 | BRD4 | 1.72309199 |
26 | NEK9 | 1.70056357 |
27 | MAP2K7 | 1.62346275 |
28 | NME2 | 1.59707579 |
29 | TNIK | 1.52297177 |
30 | PASK | 1.50947876 |
31 | TGFBR2 | 1.47116149 |
32 | YES1 | 1.45614728 |
33 | BCR | 1.44393467 |
34 | SGK3 | 1.44007045 |
35 | STK3 | 1.42965930 |
36 | STK10 | 1.42929973 |
37 | TXK | 1.38096506 |
38 | TYK2 | 1.37526554 |
39 | STK38L | 1.36113229 |
40 | CAMKK2 | 1.35144031 |
41 | BCKDK | 1.34239675 |
42 | BRSK2 | 1.33332542 |
43 | BTK | 1.32518632 |
44 | SYK | 1.29378086 |
45 | EIF2AK2 | 1.26870483 |
46 | PLK1 | 1.21393407 |
47 | CSNK1G1 | 1.19644274 |
48 | MST4 | 1.16480739 |
49 | MKNK2 | 1.15287859 |
50 | TRPM7 | 1.13102729 |
51 | MAP3K12 | 1.12931770 |
52 | VRK1 | 1.11579648 |
53 | ERBB4 | 1.10145904 |
54 | BLK | 1.09863389 |
55 | SIK1 | 1.07642242 |
56 | TAF1 | 1.07524860 |
57 | SIK2 | 1.07293437 |
58 | CLK1 | 1.06899133 |
59 | BMPR2 | 1.05418279 |
60 | NUAK1 | 1.03365036 |
61 | MAP4K1 | 1.02394028 |
62 | FLT3 | 0.99358229 |
63 | CASK | 0.98887750 |
64 | TBK1 | 0.96196901 |
65 | TESK2 | 0.93367238 |
66 | CHEK2 | 0.92975120 |
67 | LYN | 0.92092056 |
68 | ACVR1B | 0.91870498 |
69 | SGK223 | 0.91547691 |
70 | SGK494 | 0.91547691 |
71 | CSNK1G3 | 0.91474820 |
72 | BMPR1B | 0.91401837 |
73 | MOS | 0.91351599 |
74 | JAK3 | 0.89414769 |
75 | PIK3CG | 0.89388602 |
76 | PDK3 | 0.89033946 |
77 | PDK4 | 0.89033946 |
78 | RPS6KA4 | 0.87989880 |
79 | MAP3K8 | 0.83088568 |
80 | EIF2AK3 | 0.82527008 |
81 | FRK | 0.82216217 |
82 | ZAP70 | 0.80524246 |
83 | MAP3K10 | 0.79681176 |
84 | ATM | 0.78794423 |
85 | PLK2 | 0.77945528 |
86 | SRPK1 | 0.77393344 |
87 | OBSCN | 0.76955010 |
88 | MARK3 | 0.76659172 |
89 | CSNK1A1L | 0.76281251 |
90 | ADRBK2 | 0.75942749 |
91 | CCNB1 | 0.75371253 |
92 | CHUK | 0.75308151 |
93 | IKBKB | 0.74453299 |
94 | PIM1 | 0.73325438 |
95 | EIF2AK1 | 0.73269317 |
96 | CHEK1 | 0.73226888 |
97 | TSSK6 | 0.71911860 |
98 | MKNK1 | 0.71586230 |
99 | KSR1 | 0.68991529 |
100 | CSNK1G2 | 0.68461529 |
101 | STK24 | 0.66758411 |
102 | BRSK1 | 0.66117505 |
103 | GRK7 | 0.65313592 |
104 | TAOK2 | 0.63865741 |
105 | MYLK | 0.63711309 |
106 | IKBKE | 0.62748179 |
107 | PAK4 | 0.62114455 |
108 | JAK1 | 0.61677388 |
109 | TNK2 | 0.61370172 |
110 | PIM2 | 0.59248965 |
111 | AURKB | 0.56372126 |
112 | CDK9 | 0.55987423 |
113 | PLK3 | 0.53841360 |
114 | BRAF | 0.53724867 |
115 | WNK3 | 0.52840047 |
116 | CDK7 | 0.51724072 |
117 | PRPF4B | 0.51489757 |
118 | ATR | 0.51110592 |
119 | CSF1R | 0.50729814 |
120 | MELK | 0.50640055 |
121 | DYRK3 | 0.50256178 |
122 | BUB1 | 0.48809611 |
123 | TGFBR1 | 0.47505751 |
124 | CDK6 | 0.47138782 |
125 | PRKCD | 0.46095594 |
126 | RPS6KA6 | 0.45345445 |
127 | RPS6KL1 | 0.44989710 |
128 | RPS6KC1 | 0.44989710 |
129 | STK4 | 0.43818955 |
130 | FES | 0.42703881 |
131 | MAP3K5 | 0.40821343 |
132 | ARAF | 0.40145867 |
133 | CDK3 | 0.39828315 |
134 | CSNK2A1 | 0.39676734 |
135 | MATK | 0.39378300 |
136 | RPS6KB1 | 0.38470793 |
137 | LATS1 | 0.37785535 |
138 | MAPK13 | 0.36722497 |
139 | KDR | 0.35850953 |
140 | HCK | 0.35831733 |
141 | MAP3K13 | 0.34847163 |
142 | PRKCE | 0.34731771 |
143 | IGF1R | 0.34191821 |
144 | MAP3K9 | 0.30007919 |
145 | AKT2 | 0.28928700 |
146 | CSNK2A2 | 0.28509873 |
147 | RAF1 | 0.27885408 |
148 | CDK2 | 0.25792630 |
149 | CDK1 | 0.23917655 |
150 | DAPK1 | 0.23327326 |
151 | MAP3K4 | 0.23100189 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.49606752 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.13460821 |
3 | Protein export_Homo sapiens_hsa03060 | 2.99973093 |
4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.68154697 |
5 | RNA transport_Homo sapiens_hsa03013 | 2.43689875 |
6 | Spliceosome_Homo sapiens_hsa03040 | 2.43321930 |
7 | Cell cycle_Homo sapiens_hsa04110 | 2.42719146 |
8 | Proteasome_Homo sapiens_hsa03050 | 2.22483950 |
9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.19082584 |
10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07297538 |
11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.96819886 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92070572 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83866531 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82360418 |
15 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.79233531 |
16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.74988019 |
17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70879038 |
18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68447437 |
19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66341682 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63042486 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.62118686 |
22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.61541470 |
23 | Homologous recombination_Homo sapiens_hsa03440 | 1.56323969 |
24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55753963 |
25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.53736434 |
26 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.48490739 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.47365209 |
28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46116646 |
29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45021813 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.44592525 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43384110 |
32 | Peroxisome_Homo sapiens_hsa04146 | 1.40658153 |
33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39603200 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38431146 |
35 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.37982793 |
36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37226349 |
37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33897699 |
38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32683137 |
39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.32577156 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31894877 |
41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31619813 |
42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29360620 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26725602 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26043071 |
45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25660634 |
46 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.25256800 |
47 | RNA degradation_Homo sapiens_hsa03018 | 1.23244367 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18929592 |
49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18170562 |
50 | Phagosome_Homo sapiens_hsa04145 | 1.18151828 |
51 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14957180 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14501912 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13602759 |
54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12354790 |
55 | Measles_Homo sapiens_hsa05162 | 1.10296112 |
56 | DNA replication_Homo sapiens_hsa03030 | 1.09834392 |
57 | RNA polymerase_Homo sapiens_hsa03020 | 1.08619010 |
58 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08458579 |
59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08451526 |
60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07189989 |
61 | Base excision repair_Homo sapiens_hsa03410 | 1.06525842 |
62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06470046 |
63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03425762 |
64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02368281 |
65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02342246 |
66 | Pertussis_Homo sapiens_hsa05133 | 1.00946939 |
67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98516747 |
68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98410226 |
69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98112353 |
70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97586820 |
71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97039592 |
72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96579045 |
73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95231391 |
74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94924122 |
75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.93931282 |
76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.93503880 |
77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92849442 |
78 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91777849 |
79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90542946 |
80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88284441 |
81 | Mismatch repair_Homo sapiens_hsa03430 | 0.87479303 |
82 | ABC transporters_Homo sapiens_hsa02010 | 0.84738371 |
83 | Shigellosis_Homo sapiens_hsa05131 | 0.84188766 |
84 | Tuberculosis_Homo sapiens_hsa05152 | 0.83865334 |
85 | Influenza A_Homo sapiens_hsa05164 | 0.82400435 |
86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82029796 |
87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80599791 |
88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79541482 |
89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76609390 |
90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76463184 |
91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74783816 |
92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.74499585 |
93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73765463 |
94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73076294 |
95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72964384 |
96 | Hepatitis B_Homo sapiens_hsa05161 | 0.72048101 |
97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71834542 |
98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71797380 |
99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71572706 |
100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68717022 |
101 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67591226 |
102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65386678 |
103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65295989 |
104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63771565 |
105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60827942 |
106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60550449 |
107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58833638 |
108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58122183 |
109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57068254 |
110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55061339 |
111 | Malaria_Homo sapiens_hsa05144 | 0.53935247 |
112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52567635 |
113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51939649 |
114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51761359 |
115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50513912 |
116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50146688 |
117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50127825 |
118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50037420 |
119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49912299 |
120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49864706 |
121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49717848 |
122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48412533 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.47958422 |
124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46770664 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46046859 |
126 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45851085 |
127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45062100 |
128 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45008069 |
129 | Purine metabolism_Homo sapiens_hsa00230 | 0.44687968 |
130 | Bladder cancer_Homo sapiens_hsa05219 | 0.44242360 |
131 | Adherens junction_Homo sapiens_hsa04520 | 0.44087665 |
132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37870371 |
133 | Allograft rejection_Homo sapiens_hsa05330 | 0.37793123 |
134 | Asthma_Homo sapiens_hsa05310 | 0.36854951 |
135 | Apoptosis_Homo sapiens_hsa04210 | 0.32130875 |
136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30945485 |
137 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28898844 |
138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.27761666 |
139 | Salmonella infection_Homo sapiens_hsa05132 | 0.26934641 |
140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26299157 |
141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25918034 |
142 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25132055 |